Selected research
Market Outlook & Growth Opportunities
Global Animal Experimental Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Animal Experimental Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Animal Experimental Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Animal Experimental Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal Experimental Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Animal Experimental Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Animal Experimental Services market include Charles River Laboratories, The Jackson Laboratory, Labcorp, Evotec, Envigo, Shin Nippon Biomedical Laboratories, Medical & Biological Laboratories, Molecular Diagnostic Services and Mispro, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Animal Experimental Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal Experimental Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal Experimental Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Experimental Services market.
Animal Experimental Services Segment by Company
Charles River Laboratories
The Jackson Laboratory
Labcorp
Evotec
Envigo
Shin Nippon Biomedical Laboratories
Medical & Biological Laboratories
Molecular Diagnostic Services
Mispro
VHIO
The Biotech City
Taconic Biosciences
Gnovo
GenePharma
Shenzhen Advanced Medical Services
OBiO Technology
HFK Bioscience
Guochen Biotechnology
SPF Biotechnology
Bestest Biotechnology
Sangon Biotech
Sinogenetic Biotechnology
Joinn Laboratories
GemPharmatech
Medphoenix
Shanghai Model Organisms
Xuanzun Bioscience
Animal Experimental Services Segment by Type
Animal Model Construction
Pathological Detection
Animal Imaging
Others
Animal Experimental Services Segment by Application
Medicine
Chemicals
Education
Others
Animal Experimental Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Animal Experimental Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Animal Experimental Services key companies, revenue, market share, and recent developments.
3. To split the Animal Experimental Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Animal Experimental Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Animal Experimental Services significant trends, drivers, influence factors in global and regions.
6. To analyze Animal Experimental Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Experimental Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Experimental Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Experimental Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Experimental Services industry.
Chapter 3: Detailed analysis of Animal Experimental Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Animal Experimental Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Animal Experimental Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Model Construction
- Pathological Detection
- Animal Imaging
- Others
Applications
- Medicine
- Chemicals
- Education
- Others
Companies covered
- Charles River Laboratories
- The Jackson Laboratory
- Labcorp
- Evotec
- Envigo
- Shin Nippon Biomedical Laboratories
- Medical & Biological Laboratories
- Molecular Diagnostic Services
- Mispro
- VHIO
- The Biotech City
- Taconic Biosciences
- Gnovo
- GenePharma
- Shenzhen Advanced Medical Services
- OBiO Technology
- HFK Bioscience
- Guochen Biotechnology
- SPF Biotechnology
- Bestest Biotechnology
- Sangon Biotech
- Sinogenetic Biotechnology
- Joinn Laboratories
- GemPharmatech
- Medphoenix
- Shanghai Model Organisms
- Xuanzun Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Animal Experimental Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Animal Experimental Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Animal Experimental Services Market Dynamics
- 2.1 Animal Experimental Services Industry Trends
- 2.2 Animal Experimental Services Industry Drivers
- 2.3 Animal Experimental Services Industry Opportunities and Challenges
- 2.4 Animal Experimental Services Industry Restraints
3 Animal Experimental Services Market by Company
- 3.1 Global Animal Experimental Services Company Revenue Ranking in 2025
- 3.2 Global Animal Experimental Services Revenue by Company (2021-2026)
- 3.3 Global Animal Experimental Services Company Ranking (2024-2026)
- 3.4 Global Animal Experimental Services Company Manufacturing Base and Headquarters
- 3.5 Global Animal Experimental Services Company Product Type and Application
- 3.6 Global Animal Experimental Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Animal Experimental Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Animal Experimental Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Animal Experimental Services Market by Type
- 4.1 Animal Experimental Services Type Introduction
- 4.1.1 Animal Model Construction
- 4.1.2 Pathological Detection
- 4.1.3 Animal Imaging
- 4.1.4 Others
- 4.2 Global Animal Experimental Services Sales Value by Type
- 4.2.1 Global Animal Experimental Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Animal Experimental Services Sales Value by Type (2021-2032)
- 4.2.3 Global Animal Experimental Services Sales Value Share by Type (2021-2032)
5 Animal Experimental Services Market by Application
- 5.1 Animal Experimental Services Application Introduction
- 5.1.1 Medicine
- 5.1.2 Chemicals
- 5.1.3 Education
- 5.1.4 Others
- 5.2 Global Animal Experimental Services Sales Value by Application
- 5.2.1 Global Animal Experimental Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Animal Experimental Services Sales Value by Application (2021-2032)
- 5.2.3 Global Animal Experimental Services Sales Value Share by Application (2021-2032)
6 Animal Experimental Services Regional Value Analysis
- 6.1 Global Animal Experimental Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Animal Experimental Services Sales Value by Region (2021-2032)
- 6.2.1 Global Animal Experimental Services Sales Value by Region: 2021-2026
- 6.2.2 Global Animal Experimental Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Animal Experimental Services Sales Value (2021-2032)
- 6.3.2 North America Animal Experimental Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Animal Experimental Services Sales Value (2021-2032)
- 6.4.2 Europe Animal Experimental Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Animal Experimental Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Animal Experimental Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Animal Experimental Services Sales Value (2021-2032)
- 6.6.2 South America Animal Experimental Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Animal Experimental Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Animal Experimental Services Sales Value Share by Country, 2025 VS 2032
7 Animal Experimental Services Country-level Value Analysis
- 7.1 Global Animal Experimental Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Animal Experimental Services Sales Value by Country (2021-2032)
- 7.2.1 Global Animal Experimental Services Sales Value by Country (2021-2026)
- 7.2.2 Global Animal Experimental Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Animal Experimental Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Animal Experimental Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Animal Experimental Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Charles River Laboratories
- 8.1.1 Charles River Laboratories Company Information
- 8.1.2 Charles River Laboratories Business Overview
- 8.1.3 Charles River Laboratories Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River Laboratories Animal Experimental Services Product Portfolio
- 8.1.5 Charles River Laboratories Recent Developments
- 8.2 The Jackson Laboratory
- 8.2.1 The Jackson Laboratory Company Information
- 8.2.2 The Jackson Laboratory Business Overview
- 8.2.3 The Jackson Laboratory Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.2.4 The Jackson Laboratory Animal Experimental Services Product Portfolio
- 8.2.5 The Jackson Laboratory Recent Developments
- 8.3 Labcorp
- 8.3.1 Labcorp Company Information
- 8.3.2 Labcorp Business Overview
- 8.3.3 Labcorp Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Labcorp Animal Experimental Services Product Portfolio
- 8.3.5 Labcorp Recent Developments
- 8.4 Evotec
- 8.4.1 Evotec Company Information
- 8.4.2 Evotec Business Overview
- 8.4.3 Evotec Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Evotec Animal Experimental Services Product Portfolio
- 8.4.5 Evotec Recent Developments
- 8.5 Envigo
- 8.5.1 Envigo Company Information
- 8.5.2 Envigo Business Overview
- 8.5.3 Envigo Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Envigo Animal Experimental Services Product Portfolio
- 8.5.5 Envigo Recent Developments
- 8.6 Shin Nippon Biomedical Laboratories
- 8.6.1 Shin Nippon Biomedical Laboratories Company Information
- 8.6.2 Shin Nippon Biomedical Laboratories Business Overview
- 8.6.3 Shin Nippon Biomedical Laboratories Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Shin Nippon Biomedical Laboratories Animal Experimental Services Product Portfolio
- 8.6.5 Shin Nippon Biomedical Laboratories Recent Developments
- 8.7 Medical & Biological Laboratories
- 8.7.1 Medical & Biological Laboratories Company Information
- 8.7.2 Medical & Biological Laboratories Business Overview
- 8.7.3 Medical & Biological Laboratories Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Medical & Biological Laboratories Animal Experimental Services Product Portfolio
- 8.7.5 Medical & Biological Laboratories Recent Developments
- 8.8 Molecular Diagnostic Services
- 8.8.1 Molecular Diagnostic Services Company Information
- 8.8.2 Molecular Diagnostic Services Business Overview
- 8.8.3 Molecular Diagnostic Services Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Molecular Diagnostic Services Animal Experimental Services Product Portfolio
- 8.8.5 Molecular Diagnostic Services Recent Developments
- 8.9 Mispro
- 8.9.1 Mispro Company Information
- 8.9.2 Mispro Business Overview
- 8.9.3 Mispro Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Mispro Animal Experimental Services Product Portfolio
- 8.9.5 Mispro Recent Developments
- 8.10 VHIO
- 8.10.1 VHIO Company Information
- 8.10.2 VHIO Business Overview
- 8.10.3 VHIO Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.10.4 VHIO Animal Experimental Services Product Portfolio
- 8.10.5 VHIO Recent Developments
- 8.11 The Biotech City
- 8.11.1 The Biotech City Company Information
- 8.11.2 The Biotech City Business Overview
- 8.11.3 The Biotech City Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.11.4 The Biotech City Animal Experimental Services Product Portfolio
- 8.11.5 The Biotech City Recent Developments
- 8.12 Taconic Biosciences
- 8.12.1 Taconic Biosciences Company Information
- 8.12.2 Taconic Biosciences Business Overview
- 8.12.3 Taconic Biosciences Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Taconic Biosciences Animal Experimental Services Product Portfolio
- 8.12.5 Taconic Biosciences Recent Developments
- 8.13 Gnovo
- 8.13.1 Gnovo Company Information
- 8.13.2 Gnovo Business Overview
- 8.13.3 Gnovo Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Gnovo Animal Experimental Services Product Portfolio
- 8.13.5 Gnovo Recent Developments
- 8.14 GenePharma
- 8.14.1 GenePharma Company Information
- 8.14.2 GenePharma Business Overview
- 8.14.3 GenePharma Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.14.4 GenePharma Animal Experimental Services Product Portfolio
- 8.14.5 GenePharma Recent Developments
- 8.15 Shenzhen Advanced Medical Services
- 8.15.1 Shenzhen Advanced Medical Services Company Information
- 8.15.2 Shenzhen Advanced Medical Services Business Overview
- 8.15.3 Shenzhen Advanced Medical Services Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Shenzhen Advanced Medical Services Animal Experimental Services Product Portfolio
- 8.15.5 Shenzhen Advanced Medical Services Recent Developments
- 8.16 OBiO Technology
- 8.16.1 OBiO Technology Company Information
- 8.16.2 OBiO Technology Business Overview
- 8.16.3 OBiO Technology Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.16.4 OBiO Technology Animal Experimental Services Product Portfolio
- 8.16.5 OBiO Technology Recent Developments
- 8.17 HFK Bioscience
- 8.17.1 HFK Bioscience Company Information
- 8.17.2 HFK Bioscience Business Overview
- 8.17.3 HFK Bioscience Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.17.4 HFK Bioscience Animal Experimental Services Product Portfolio
- 8.17.5 HFK Bioscience Recent Developments
- 8.18 Guochen Biotechnology
- 8.18.1 Guochen Biotechnology Company Information
- 8.18.2 Guochen Biotechnology Business Overview
- 8.18.3 Guochen Biotechnology Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Guochen Biotechnology Animal Experimental Services Product Portfolio
- 8.18.5 Guochen Biotechnology Recent Developments
- 8.19 SPF Biotechnology
- 8.19.1 SPF Biotechnology Company Information
- 8.19.2 SPF Biotechnology Business Overview
- 8.19.3 SPF Biotechnology Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.19.4 SPF Biotechnology Animal Experimental Services Product Portfolio
- 8.19.5 SPF Biotechnology Recent Developments
- 8.20 Bestest Biotechnology
- 8.20.1 Bestest Biotechnology Company Information
- 8.20.2 Bestest Biotechnology Business Overview
- 8.20.3 Bestest Biotechnology Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Bestest Biotechnology Animal Experimental Services Product Portfolio
- 8.20.5 Bestest Biotechnology Recent Developments
- 8.21 Sangon Biotech
- 8.21.1 Sangon Biotech Company Information
- 8.21.2 Sangon Biotech Business Overview
- 8.21.3 Sangon Biotech Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.21.4 Sangon Biotech Animal Experimental Services Product Portfolio
- 8.21.5 Sangon Biotech Recent Developments
- 8.22 Sinogenetic Biotechnology
- 8.22.1 Sinogenetic Biotechnology Company Information
- 8.22.2 Sinogenetic Biotechnology Business Overview
- 8.22.3 Sinogenetic Biotechnology Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.22.4 Sinogenetic Biotechnology Animal Experimental Services Product Portfolio
- 8.22.5 Sinogenetic Biotechnology Recent Developments
- 8.23 Joinn Laboratories
- 8.23.1 Joinn Laboratories Company Information
- 8.23.2 Joinn Laboratories Business Overview
- 8.23.3 Joinn Laboratories Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.23.4 Joinn Laboratories Animal Experimental Services Product Portfolio
- 8.23.5 Joinn Laboratories Recent Developments
- 8.24 GemPharmatech
- 8.24.1 GemPharmatech Company Information
- 8.24.2 GemPharmatech Business Overview
- 8.24.3 GemPharmatech Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.24.4 GemPharmatech Animal Experimental Services Product Portfolio
- 8.24.5 GemPharmatech Recent Developments
- 8.25 Medphoenix
- 8.25.1 Medphoenix Company Information
- 8.25.2 Medphoenix Business Overview
- 8.25.3 Medphoenix Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.25.4 Medphoenix Animal Experimental Services Product Portfolio
- 8.25.5 Medphoenix Recent Developments
- 8.26 Shanghai Model Organisms
- 8.26.1 Shanghai Model Organisms Company Information
- 8.26.2 Shanghai Model Organisms Business Overview
- 8.26.3 Shanghai Model Organisms Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.26.4 Shanghai Model Organisms Animal Experimental Services Product Portfolio
- 8.26.5 Shanghai Model Organisms Recent Developments
- 8.27 Xuanzun Bioscience
- 8.27.1 Xuanzun Bioscience Company Information
- 8.27.2 Xuanzun Bioscience Business Overview
- 8.27.3 Xuanzun Bioscience Animal Experimental Services Revenue and Gross Margin (2021-2026)
- 8.27.4 Xuanzun Bioscience Animal Experimental Services Product Portfolio
- 8.27.5 Xuanzun Bioscience Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst